Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
March 18, 2019 14:22 ET
|
Amphera B.V.
Proprietary immuno-oncology approach harnesses autologous dendritic cell therapy to treat an orphan-designated cancer `s-Hertogenbosch, The Netherlands, March 18, 2019 (GLOBE NEWSWIRE) -- via...